Spark Biopharma

Spark Biopharma is a South Korean biotechnology company focused on the development of innovative, first-in-class small-molecule therapeutics. The company utilizes a proprietary drug discovery platform based on phenotypic screening, proteomics, and chemical biology to identify novel therapeutic targets and candidates for various diseases, including cancer, metabolic, and CNS disorders. Beyond drug discovery, the company is actively involved in the South Korean bio-startup ecosystem. It operates 'MediOpenLab,' a shared laboratory platform, and is collaborating with local governments (such as Pohang City) and medical institutions to establish research-clinical integrated systems and specialized clinical hospitals to foster bio-industry clusters.